| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |